Cargando…
In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells
BACKGROUND: Tumours consist of heterogeneous cancer cells and are likely to contain drug-tolerant cell subpopulations, causing early relapse. However, treatment strategies to eliminate these cells have not been established. METHODS: We established gastric cancer patient-derived cells (PDCs) to exami...
Autores principales: | Mashima, Tetsuo, Iwasaki, Risa, Kawata, Naomi, Kawakami, Ryuhei, Kumagai, Koshi, Migita, Toshiro, Sano, Takeshi, Yamaguchi, Kensei, Seimiya, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889183/ https://www.ncbi.nlm.nih.gov/pubmed/31607750 http://dx.doi.org/10.1038/s41416-019-0600-9 |
Ejemplares similares
-
ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer
por: Kawakami, Ryuhei, et al.
Publicado: (2020) -
Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo
por: Mashima, Tetsuo, et al.
Publicado: (2021) -
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer
por: Suenaga, Mitsukuni, et al.
Publicado: (2016) -
Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib
por: Matsusaka, Satoshi, et al.
Publicado: (2020) -
4,4′-Bipyridine-1,1′-diium 2,3,5,6-tetrabromoterephthalate dihydrate
por: Kumagai, Hitoshi, et al.
Publicado: (2011)